Red Cat surges following a five-year contract with NASA for its Skypersonic subsidiary Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Red Cat (RCAT) up 48% after its subsidiary, Skypersonic, was awarded a five-year contract with NASA to provide drone and rover software, hardware and support for its Simulated Mars mission
- Gores Guggenheim (GGPI) up 2% after Polestar Performance AB (PSNY) and its affiliates and the company announced that they have entered into a definitive business combination agreement in which a new public company that will be named Polestar Automotive Holding UK Limited, which is expected to be listed on Nasdaq
- Aspen Group (ASPU) up 6% after announcing that board member Douglas Kass bought 32,000 shares of common stock on September 22 in a total transaction size of $172,000, boosting his stake by about 62%
- Vinco Ventures (BBIG) up 21% as the stock is the highest trending ticker on StockTwits and is also in the top-10 on WallStreetBets Reddit thread in terms of message volume over the past 24 hours
- NRx Pharmaceuticals (NRXP) up 4% after announcing top line data demonstrating improved outcomes at one year in highly comorbid patients with COVID-19 who were treated with Zyesami
LOWER -
- Facebook (FB) down 1% after announcing a decision to pause work on Instagram Kids
- Aslan Pharmaceuticals (ASLN) down 28% after announcing topline data from its randomized, double-blind, placebo-controlled, 8-week, multiple-ascending-dose Phase 1 study of ASLAN004 for the treatment of moderate-to-severe atopic dermatitis
- Evelo Biosciences (EVLO) down 15% after announcing data from its Phase 2 study evaluating EDP1815 versus placebo for the treatment of mild and moderate psoriasis
- Capricor Therapeutics (CAPR) down 6% after announcing final data from the HOPE-2 clinical trial using CAP-1002 to treat patients in advanced stages of Duchenne muscular dystrophy
- Opoko Health (OPK) down 15% after announcing that the FDA has extended the review period for the biologics license application for somatrogon, a once-weekly long-acting recombinant human growth hormone, for the treatment of growth hormone deficiency in pediatric patients
Symbols:
RCAT GGPI ASPU BBIG NRXP FB ASLN EVLO CAPR OPK Keywords: Fly Intel, Wall Street, Top Stories, Stocks